Clinical Trial Update: Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV [Phase 1, Phase 2]

View source ↗

Summary

Safety-focused clinical trial update evaluating saquinavir and high-dose lopinavir/ritonavir in pediatric HIV patients (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Lopinavir/ritonavir (lopinavir/ritonavir)
• Saquinavir (saquinavir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED